-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cardiff Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2023.
- Cardiff Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 46.9M shares, a 4.9% increase year-over-year.
- Cardiff Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 44.7M shares, a 2.47% increase from 2022.
- Cardiff Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 43.6M shares, a 11.7% increase from 2021.
- Cardiff Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 39M shares, a 87% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)